Companies
/Healthcare
Morphosys AG
$18.96
▲ $0.00 (+0.00%) today
Markets closed · 7:15pm ET
Today · % change
Fundamentals
Market Cap
$2.9B
Profit Margin
-190.6%
Revenue (TTM)
$241.5M
EPS (TTM)
$-1.50
Street Target
$15.58
About MOR
MorphoSys AG is a biopharmaceutical company based in Germany, focused on developing therapeutic antibodies for cancer and autoimmune diseases. It has brought to market Tafasitamab for B cell malignancies and is working on treatments for conditions like myelofibrosis, autoimmune diseases, Alzheimer’s, and rheumatoid arthritis. The company collaborates globally, including partnerships for developing and commercializing its products in various regions. Founded in 1992, MorphoSys stands out for its commitment to addressing unmet medical needs through innovative therapies.